Beal, M. Flint

Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia

Yin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M. T., Beal, M. F., Nathan, C., Thomas, B., & Ding, A. (2010) · The FASEB Journal

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 180

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

Dedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry

Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments

Cited by 169

Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

Petri, S., Kiaei, M., Damiano, M., Hiller, A., Wille, E., Manfredi, G., Calingasan, N. Y., Szeto, H. H., & Beal, M. F. (2006) · Journal of Neurochemistry

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 166

Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons

Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 158

Manganese Superoxide Dismutase Overexpression Attenuates MPTP Toxicity

Klivenyi, P., St. Clair, D., Wermer, M., Yen, H.-C., Oberley, T., Yang, L., & Beal, M. F. (1998) · Neurobiology of Disease

Parkinson's Disease Mechanisms and TreatmentsGlutathione Transferases and Polymorphisms

Cited by 142

PGC-1α, a New Therapeutic Target in Huntington's Disease?

McGill, J. K., & Beal, M. F. (2006) · Cell

Genetic Neurodegenerative DiseasesMitochondrial Function and Pathology

Cited by 131

Lipoic acid improves survival in transgenic mouse models of Huntington's disease

Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., & Beal, M. F. (2001) · Neuroreport

Genetic Neurodegenerative DiseasesBiochemical Acid Research Studies

Cited by 115

The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 55

PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

Lloret, A., & Beal, M. F. (2019) · Neurochemical Research

Sirtuins and Resveratrol in MedicineGenetic Neurodegenerative Diseases

Cited by 52

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10

Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters

Parkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects

Cited by 23